Roger A. Pedersen
Corporate Officer/Principal at University of Cambridge
Profile
Roger A.
Pedersen is the founder of DefiniGEN Ltd.
which was founded in 2012.
Currently, he is a Professor at the University of Cambridge.
Dr. Pedersen completed his undergraduate degree from Stanford University in 1965 and his doctorate degree from Yale University in 1970.
Roger A. Pedersen active positions
| Companies | Position | Start |
|---|---|---|
| University of Cambridge | Corporate Officer/Principal | - |
Former positions of Roger A. Pedersen
| Companies | Position | End |
|---|---|---|
DefiniGEN Ltd.
 DefiniGEN Ltd. Miscellaneous Commercial ServicesCommercial Services DefiniGEN Ltd. provides human cell products to the drug discovery sector. Its services include iPSC Differentiation, Gene Editing, CRISPR Modeling and Patient Derived Models. The firm products include Hepatocytes, Intestinal and Pancreatic. The company was founded in April 2012 by Candy Hsin-Hua Cho, Nicolas R. F. Hannan, Roger A. Pedersen and Tamir Rashid and is headquartered in Cambridge, the United Kingdom. | Founder | - |
Training of Roger A. Pedersen
| Stanford University | Undergraduate Degree |
| Yale University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
DefiniGEN Ltd.
DefiniGEN Ltd. Miscellaneous Commercial ServicesCommercial Services DefiniGEN Ltd. provides human cell products to the drug discovery sector. Its services include iPSC Differentiation, Gene Editing, CRISPR Modeling and Patient Derived Models. The firm products include Hepatocytes, Intestinal and Pancreatic. The company was founded in April 2012 by Candy Hsin-Hua Cho, Nicolas R. F. Hannan, Roger A. Pedersen and Tamir Rashid and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Roger A. Pedersen
